RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here's Why
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the top gene therapy stocks to buy according to hedge funds. On February 25, RBC Capital adjusted the price target on Beam Therapeutics Inc.







